GSK plc (GSK)
NYSE: GSK · IEX Real-Time Price · USD
38.21
-0.17 (-0.44%)
At close: Jul 2, 2024, 4:00 PM
38.35
+0.14 (0.37%)
After-hours: Jul 2, 2024, 7:43 PM EDT
GSK Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for GSK stock have an average target of 48, with a low estimate of 44 and a high estimate of 53. The average target predicts an increase of 25.62% from the current stock price of 38.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GSK stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +38.71% | Jul 2, 2024 |
Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +23.00% | May 30, 2024 |
Guggenheim | Guggenheim | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 4, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $44 | Hold | Initiates | $44 | +15.15% | Jan 23, 2024 |
Jefferies | Jefferies | Hold → Strong Buy Upgrades $39 → $48 | Hold → Strong Buy | Upgrades | $39 → $48 | +25.62% | Jan 3, 2024 |
Financial Forecast
Revenue This Year
32.67B
from 30.33B
Increased by 7.74%
Revenue Next Year
34.75B
from 32.67B
Increased by 6.34%
EPS This Year
1.64
from 2.40
Decreased by -31.40%
EPS Next Year
1.82
from 1.64
Increased by 10.78%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 34.0B | 36.7B | 40.1B | 44.7B | 46.6B |
Avg | 32.7B | 34.7B | 36.5B | 38.6B | 39.0B |
Low | 30.5B | 32.0B | 33.2B | 34.3B | 33.2B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 12.3% | 12.4% | 15.5% | 22.4% | 20.7% |
Avg | 7.7% | 6.3% | 5.2% | 5.7% | 1.1% |
Low | 0.5% | -2.0% | -4.3% | -6.0% | -14.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.76 | 1.98 | 2.25 | 2.47 | 2.56 |
Avg | 1.64 | 1.82 | 2.01 | 2.23 | 2.27 |
Low | 1.52 | 1.47 | 1.59 | 2.01 | 1.98 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -26.8% | 20.5% | 23.6% | 23.2% | 14.7% |
Avg | -31.4% | 10.8% | 10.1% | 11.0% | 1.9% |
Low | -36.7% | -10.4% | -12.8% | 0.2% | -11.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.